EQUITY Equity (Tables)
|
9 Months Ended |
Sep. 30, 2021 |
|---|
| Equity [Abstract] |
|
| Schedule of Accumulated Other Comprehensive Income (Loss) |
The following table presents changes in the components of AOCI, net of taxes, for the nine months ended September 30, 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flow Hedge |
|
Foreign Currency Items |
|
Total |
|
(in thousands) |
| Balance at December 31, 2020 |
$ |
(31,587) |
|
|
$ |
(145,422) |
|
|
$ |
(177,009) |
|
Other comprehensive income before reclassifications |
10,160 |
|
|
(10,001) |
|
|
159 |
|
| Amount reclassified from AOCI |
5,853 |
|
|
— |
|
|
5,853 |
|
| Net other comprehensive income |
16,013 |
|
|
(10,001) |
|
|
6,012 |
|
| Balance at September 30, 2021 |
$ |
(15,574) |
|
|
$ |
(155,423) |
|
|
$ |
(170,997) |
|
|
| Schedule of Weighted Average Number of Shares |
The following table sets forth the computation of weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
|
| Weighted average common shares—basic |
216,888,355 |
|
|
212,593,719 |
|
|
215,716,239 |
|
|
211,781,620 |
|
| Effect of dilutive securities: |
|
|
|
|
|
|
|
| Stock options and restricted stock |
6,912,045 |
|
|
— |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
| Weighted average common shares—diluted |
223,800,400 |
|
|
212,593,719 |
|
|
215,716,239 |
|
|
211,781,620 |
|
|
| Potentially Dilutive Securities Excluded From Diluted Net Income (Loss) Per Common Share |
The following table shows securities excluded from the calculation of diluted net loss per common share because such securities are anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
| Options to purchase shares of common stock |
3,750 |
|
|
9,874,376 |
|
|
7,727,064 |
|
|
9,874,376 |
|
| Restricted stock and deferred stock—unvested |
91,275 |
|
|
3,713,249 |
|
|
3,207,115 |
|
|
3,713,249 |
|
|
|
|
|
|
|
|
|
| Conversion shares related to the convertible senior notes |
11,864,035 |
|
|
11,864,035 |
|
|
11,864,035 |
|
|
10,729,717 |
|
| Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding |
11,959,060 |
|
|
25,451,660 |
|
|
22,798,214 |
|
|
24,317,342 |
|
|